Financing and Investment

Fresenius plans to buy Renal Care for about $4 billion

BERLIN – Fresenius Medical Care AG (NYSE: FMS), already the world’s largest provider of kidney dialysis services, disclosed last month that it plans to buy Nashville, Tenn.-based Renal Care Group Inc. (NYSE: RCI) for about $4 billion in cash and assumed debt.

Officials of Bad Homburg, Germany-based Fresenius say they hope to close the deal during the second half of 2005, subject to approval by Renal Care’s shareholders, as well as regulatory approvals in the United States and Europe. The firm said it will pay $48 per share – a 22 percent premium over Renal Care’s stock price prior to the announcement – for a total of about

The full content of this article is only available to paid subscribers. If you are an active subscriber, please log in. To subscribe, please click here: SUBSCRIBE

Existing Users Log In

Comments are closed, but trackbacks and pingbacks are open.